ALBANY — As New York prepares to expand its medical marijuana program to include people who are prescribed opioids, advocates are urging the state to simultaneously increase the number of dispensing sites.
The expansion is a big deal to patient advocates, who have criticized the state's program as one of the most restrictive in the nation. While state Health Commissioner Howard Zucker said Monday he is unsure how many more individuals would be made eligible for the program as a result of the change, it is sure to be many, as prescription opioids like hydrocodone, oxycodone and morphine remain the most common treatment for pain in America.
"This means anyone who is taking prescription opioids can now use medical marijuana under our program, and our goal is for them to eventually get to a point where they can hopefully come off the opioids altogether," he said.
Top photo courtesy of Adobe Stock
Latest from Cannabis Business Times
- Nebraska AG Announces Felony Charge Related to Fraudulent Signature Investigation of Cannabis Petitions
- Former Nebraska Senator Files Lawsuit Challenging State’s Medical Cannabis Ballot Initiatives
- Verano Opens 2 More MÜV Dispensaries in Florida
- Green Thumb Industries Refinances Senior Debt, Closing on $150 Million Syndicated Credit Facility
- Planet 13 Enters Agreement to Acquire Las Vegas Dispensary
- Michigan Dispensaries Set Monthly Sales Record in August, Closing Gap on California
- MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research
- 24 Adult-Use Dispensary Licenses Still Up for Grabs in Rhode Island via Lottery